Health Minister Jens Spann warned from the outset that miracles should not be expected from this meeting of heads of regional governments, EU representatives and drug committees.
“A summit will not produce more vaccines,” he said.
However, with the commitment of many laboratories to accelerate the production of anti-Govt vaccines, negotiations began in positive sponsorship.
German bioentech announced this morning that 75 million additional volumes created with Americans from Pfizer would arrive in the EU in the second quarter.
Bayer, a German industrial company, is currently committed to producing vaccines with another laboratory in the country, Quervac.
Earlier in the day, European Commission President Ursula van der Leyen announced that the Anglo-Swedish group AstroZeneca would be fired by critics of European leaders after significant delays in production, and that it would deliver an additional 9 million doses compared to what was offered this week. , So a total dose of 40 million.
The purpose of the summit, first and foremost, is to formulate a strategy for rapid and effective vaccination in the EU, which will have approximately 320 million doses this year, subject to the approval of Curvac and Johnson & Johnson vaccines. The document of the Ministry of Health was consulted by the AFP.
A press conference is scheduled for the end of the summit.
German newspapers on Monday were ruthless to the EU, accusing it of ordering vaccines too late and negotiating badly, especially with AstraZeneca.
There is currently a lower vaccination record in Europe than in the United Kingdom, where Brexit supporters see these figures as confirming their decision to leave the EU.
Germany’s popular newspaper Bild accused it of being “a declaration of bankruptcy to Brussels, a testament to the disability of the 27 member states.”
“In the worst crisis since World War II, how can vaccines be ignored in this way,” Der Spiegel wrote.
While the European Union has developed a $ 750 billion economic support package to tackle the effects of the epidemic, it has only invested nearly $ 3 billion in the provision of vaccines, which is “difficult to justify,” the release said.
Ursula van der Leyen has attracted particular attention from critics, with some, such as the far-right Apti Party, calling for him to step down.
“He was dealt a severe blow, but I do not think he will leave,” a European diplomatic source said.
Rebellion in the ruling coalition
The current turmoil could weaken the government’s position just months before the September assembly elections.
The role of the Conservative Party’s popularity in recent months has largely been based on well-regarded epidemic management, which helped Europe’s largest economy survive well into the spring, before being hit hard by the second wave. From this winter.
But the defeats during the vaccination campaign gave the impression that even the ruling coalition, which had ruled the country for nearly 16 years, had lost control of the president, causing unrest.
Finance Minister and Social Democratic presidential candidate Olaf Scholes has stepped up attacks on Health Minister Jens Spann and, indirectly, President Merkel, calling for a real “vaccination strategy.”
The party, which is facing difficulties in the election, is trying to start its legislative campaign.